Involvement of nigro-striatal neurons in the in vivo release of dopamine by amphetamine, amantadine and tyramine.
D000547:Amantadine / Q000494:pharmacology*; D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D002415:Cats; D002421:Caudate Nucleus / Q000032:analysis / Q000033:anatomy & histology; D003913:Dextroamphetamine / Q000494:pharmacology*; D004298:Dopamine / Q000032:analysis / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D004558:Electric Stimulation; D005260:Female; D008297:Male; D009474:Neurons / Q000502:physiology; D009638:Norepinephrine / Q000032:analysis; D009929:Organ Size; D010477:Perfusion; D012701:Serotonin / Q000032:analysis; D013378:Substantia Nigra / Q000502:physiology*; D014316:Tritium; D014439:Tyramine / Q000494:pharmacology*
D014316:Tritium; D012701:Serotonin; D000547:Amantadine; D000661:Amphetamine; D003913:Dextroamphetamine; D004298:Dopamine; D009638:Norepinephrine; D014439:Tyramine